Sweden· SE-20031024000022
Arixtra 1,5 mg/0,3 ml Injektionsvätska, lösning i förfylld spruta
A medicinal product containing fondaparinux sodium, registered in Sweden by Viatris Healthcare Limited.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Fondaparinux Sodium
- Manufacturer
- Viatris Healthcare Limited
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20031024000022
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fondaparinux sodium in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaARIXTRAVIATRIS HEALTHCARE LIMITED, Dublin
- SpainARIXTRA 1,5 MG/0,3 ML SOLUCION INYECTABLE, JERINGA PRECARGADAViatris Healthcare Limited
- SwitzerlandArixtra
- BelgiumArixtra 1.5 mg/0.3 mlViatris Healthcare
- FinlandQuixidarGlaxo Group Ltd
- IcelandArixtraViatris Healthcare Limited
- PolandArixtraViatris Healthcare Limited
- NorwayArixtraViatris Healthcare Limited
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Germany · Fondaparinux-Natrium Beta
- France · Fondaparinux Sodique Aspen
- United Kingdom (Northern Ireland) · Fondaparinux Sodium Dr. Reddy's
- Ireland · Fondaparinux Sodium Aspen
- Iceland · Arixtra
- Liechtenstein · Arixtra
- Norway · Arixtra
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/73810f58-178a-4787-b577-dd085c9ffa93 GET /v1/drugs/73810f58-178a-4787-b577-dd085c9ffa93?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA",
"DHPC"
],
"se_npl_id": "20031024000022",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20031024000022",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/arixtra-epar-product-information_sv.pdf"
}See everything about fondaparinux sodium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.